MAQI2 Anticoagulation Toolkit Desktop Reference

This activity includes access to the MAQI2 Anticoagulation Toolkit Desktop Reference document. This document covers information, guidelines, and best practices around oral anticoagulants. By reviewing the document and completing the evaluation, participants will have a better understanding of the latest research and guidelines and more safely and effectively manage patients on oral anticoagulants.

View Content and Claim Credit

Click the Begin button above to view the educational content and claim credit. Please note: An account on this website is required to claim credit. Please login or create an account to get started.

Release Date: 12/01/2024
Expiration Date: 11/30/2027

1. select the most appropriate oral anticoagulant for various indications and patient factors.
2. develop appropriate periprocedural plans related to anticoagulation stoppage, bridging, and restart.
3. identify inappropriate use of anticoagulation and antiplatelet combination therapy.
4. select the appropriate INR target range and length of treatment in patients requiring warfarin therapy.
5. evaluate ischemic stroke risk and need for anticoagulation in atrial fibrillation based on patient risk factors.

Questions? Please contact Brian Haymart

Michigan Anticoagulation Quality Improvement Initiative (MAQI2) Anticoagulation Toolkit. https://anticoagulationtoolkit.org/providers

Joglar, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation Circulation. 2023;148:e00–e00. DOI: 10.1161/CIR.0000000000001193

Douketis et al. Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline, Chest, Volume 162, Issue 5, 2022, Pages e207-e243, ISSN 00123692, https://doi.org/10.1016/j.chest.2022.07.025.

Kumbhani, et al. 2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients with Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Diseases. J Am Coll Cardiol. 2021 Feb 9;77(5):629-658. doi: 10.1016/j.jacc.2020.09.011. Epub 2020 Nov 26. PMID: 33250267

Mitigation of Relevant Financial Relationships

The University of Michigan Medical School adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to control the content of a CE activity, including faculty, planners, or others are required to disclose all relevant financial relationships with ineligible entities. All relevant financial relationships have been mitigated.

All of the relevant financial relationships listed for this individual have been mitigated.